PVI
PACB icon

Pura Vida Investments’s Pacific Biosciences PACB Stock Holding History

Pura Vida Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,700,000
Closed -$9.86M – 232
2022
Q3 		$9.86M Buy
1,700,000
+50,000
+3% +$287K 0.57% 50
2022
Q2 		$7.29M Buy
1,650,000
+300,000
+22% +$1.82M 0.42% 63
2022
Q1 		$12.3M Buy
1,350,000
+772,900
+134% +$8.9M 0.4% 67
2021
Q4 		$11.8M Sell
577,100
-122,900
-18% -$2.97M 0.43% 61
2021
Q3 		$17.9M Buy
+700,000
New +$20.7M 0.54% 46

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pura Vida Investments's PACB Position: Q4 2023 in Review

Pura Vida Investments sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 415,000 shares — an estimated $3.47M sold.

Pura Vida Investments first reported a position in PACB in Q3 2018 and held it in 9 quarters. The position peaked at $20.1M in Q4 2020. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Pura Vida Investments reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Pura Vida Investments sold 415,000 Pacific Biosciences shares in Q4 2023, an estimated $3.47M.
  • Pura Vida Investments first reported a position in Pacific Biosciences in Q3 2018 and held it in 9 quarters.
  • Pura Vida Investments's Pacific Biosciences position peaked at $20.1M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.